He Eye Hospital
Shenyang, Liaoning, 110034, China
NCT Number: NCT06354309
The research project titled "The Impact of Immersive Virtual Reality Training on Adult: Motion Sickness, and Ocular Surface: A Pilot Study" aimed to evaluate the initial safety impact of head-mounted virtual reality (HMVR) devices with virtual reality amblyopia training games on postural stability, motion sickness, and ocular surface in healthy adult participants. 38 adults (76 eyes) with normal corrected vision and stereo vision were recruited. All subjects used HMVR device for two consecutive training sessions (30 minutes each, 10 minutes intervals). Before training, after the first training and the second training, recorded the results including best corrected visual acuity (BCVA), ocular position, stereo vision, postural stability, non-invasive tear breakup time (NITBUT), tear meniscus height (TMH), red eye analysis, lipid layer classification (TFLL), eye blink frequency, eye surface temperature, simulator sickness questionnaire (SSQ) score, ocular surface disease index (OSDI) dry eye questionnaire score, visual quality questionnaire score and visual fatigue questionnaire score.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Shenyang, Liaoning, 110034, China
3.1Research equipment Pico VR all-in-one (Neo2 Lite, Hainan Creative Vision Future Technology Co., LTD., China (referred to as "PICO") is a VR headset, which is used together with BeiShiYou visual function training software (BV-2, Shenyang BeiYou Technology Co., LTD., referred to as "BeiShiYou") 3.2 Procedure The procedure was divided into four steps: A. Sign the informed consent. B. First ophthalmic examination (diopter, BCVA, ocular position, stereo vision, postural stability, non-invasive tear breakup time, tear meniscus height, red eye analysis, lipid layer classification, eye blink frequency, eye surface temperature) and questionnaires survey (simulator sickness questionnaire, semans balance disorder scale, ocular surface disease index dry eye questionnaire, visual quality questionnaire and visual fatigue questionnaire). C. Conduct the first VR headset game training for 30 minutes, and then conduct the second eye examination and questionnaire survey above. D. Conduct the second VR headset game training for 30 minutes, and then conduct the third eye examination and questionnaire survey above (Figure 2).
3.3 Observation Indicators includes Simulator sickness questionnaire (SSQ), Postural stability, Non-invasive tear breakup time (NITBUT), Tear meniscus height, Lipid layer classification, Eye blink frequency, Central ocular surface temperature, Dry eye questionnaire score, Visual quality questionnaire score, Visual fatigue score.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pre and post control study after use virtual reality game
Time frame: Baseline, 30min, 60min
Record the simulator sickness questionnaire score after use virtual reality game
Time frame: Baseline, 30min, 60min
Record the postural stability level after use virtual reality game
Time frame: Baseline, 30min, 60min
Check with Eye Surface Analyzer (OCULUS, Germany)
Time frame: Baseline, 30min, 60min
Check with Eye Surface Analyzer (OCULUS, Germany)
Time frame: Baseline, 30min, 60min
Check with DR-1 dry eye measurement
Time frame: Baseline, 30min, 60min
Collect the blink frequency with DJI Pocket 2 Creator Combo (Shenzhen DJI Innovation Technology Co., LTD.)
Time frame: Baseline, 30min, 60min
Collect eye surface temperature with Flir ONE Pro mobile phone Infrared thermal camera for Apple IOS (Teledyne FLIR, USA)
Time frame: Baseline, 30min, 60min
Record with OSDI questionaire
Time frame: Baseline, 30min, 60min
Record with visual quality questionnaire
Time frame: Baseline, 30min, 60min
Record with visual fatigue questionaire
He Eye Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02983552
Amblyopia, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05732467
Amblyopia, Brain Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT06372548
Adherence, Treatment, Amblyopia
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07437807
Amblyopia, Brain Diseases
Istanbul, Turkey (Türkiye)
View Trial Details